The Food and Drug Administration today approved a new drug that reduces the tendency for blood cells in people with sickle cell disease to stick together and block blood vessels. . . . → Read More: FDA Approves Sickle Cell Drug
|
|||||
|
|
An assessment by Dutch health authorities concludes mosquitoes genetically engineered to produce offspring that die before adulthood pose few health or environmental risks to humans. . . . → Read More: Little Health Impact Found from Engineered Mosquitoes The U.S. Food and Drug Administration approved use of vagus nerve stimulation to treat epilepsy in children who do not respond to drug therapy as young as 4 years old. . . . → Read More: Nerve Stimulation Approved for Children’s Epilepsy  Comments are closed  Regulations  biomedical, engineering, Europe, FDA, life sciences, medical device, physical sciences, U.K. The U.S. Food and Drug Administration approved a new drug that treats serious bacterial skin infections, including those often resistant to current antibiotics. . . . → Read More: FDA Approves Skin Infection Drug Comments are closed Regulations biomedical, clinical trials, FDA, health care, life sciences, pharmaceuticals The U.S. Food and Drug Administration expects to unveil a new procedure for certifying digital medical devices that the agency says should speed their entry to the market. . . . → Read More: FDA Developing Digital Device Certification Process Comments are closed Regulations biomedical, engineering, FDA, life sciences, medical device, software The U.S. Supreme Court ruled yesterday that makers of biologic drugs similar to branded originals need not wait an additional 6 months to begin marketing their products. . . . → Read More: Supreme Court Cuts Biosimilar Waiting Time Comments are closed Intellectual property, Regulations biomedical, biotechnology, cancer, FDA, life sciences, patent, pharmaceuticals A clinical trial is underway testing the safety and practicality of using a person’s own freeze-dried blood plasma for transfusions, substituting for frozen or liquid plasma. . . . → Read More: Trial Begins of Freeze-Dried Blood Plasma Comments are closed New products, Regulations biomedical, chemistry, clinical trials, DoD, FDA, life sciences, pharmaceuticals, university An early-stage clinical trial will soon begin testing spherically-shaped nanoscale particles to treat glioblastoma, an aggressive form of brain cancer. . . . → Read More: Trial to Test Spherical Nanotech Brain Cancer Drug Comments are closed New products, Regulations biomedical, biotechnology, cancer, clinical trials, FDA, genomics, life sciences, materials science, nanotechnology, physical sciences, university A licensing deal with a potential value of more than $2 billion between two biotechnology companies for a new breast cancer drug was cancelled on Friday. . . . → Read More: $2 Billion Biotech Licensing Deal Cancelled Comments are closed Finance, Intellectual property biomedical, biotechnology, cancer, clinical trials, equity, FDA, investment, licensing, life sciences, pharmaceuticals, venture capital The Food and Drug Administration sent warning letters to 14 companies in the U.S. that the agency says are selling products fraudulently claiming to prevent, diagnose, treat, or cure cancer. . . . → Read More: FDA Warns Cancer Fraud Product Providers |
A Thinking Person’s Artificial Intelligence Do You Want Your Bacon CRISPR? Health Care, Precisely One Person at a Time Let Guinea Pigs be Guinea Pigs Look Out Pharma. The Tech Industry is After You |
|||
|
Copyright © 2017 Technology News and Literature - All Rights Reserved Powered by WordPress & Atahualpa |
|||||
